Davies Jane C, Ebdon Anne-Marie, Orchard Christopher
Imperial College, London, UK Royal Brompton and Harefield NHS Foundation Trust, London, UK.
Royal Brompton and Harefield NHS Foundation Trust, London, UK.
Arch Dis Child. 2014 Nov;99(11):1033-6. doi: 10.1136/archdischild-2013-304400. Epub 2014 Jul 4.
Cystic fibrosis is a disease that still causes a reduced life expectancy. The treatment burden remains high for affected individuals with often a combination of multiple oral and inhaled medications, as well as physiotherapy, required on a daily basis. In this article, we look at an overview of the pathogenesis, how this might lead to treatment options and look at some of the available new therapies, all in the aim of increasing life expectancy and reducing treatment burden.
囊性纤维化是一种仍会导致预期寿命缩短的疾病。对于受影响的个体来说,治疗负担仍然很重,通常每天需要联合使用多种口服和吸入药物,以及进行物理治疗。在本文中,我们将概述其发病机制,这可能如何导致治疗选择,并探讨一些现有的新疗法,所有这些都是为了提高预期寿命和减轻治疗负担。